About this trial
Last updated 4 years ago
Study ID
Status
Type
Phase
Placebo
Accepting
Not accepting
Trial Timing
Ended 4 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- Availability, willingness and sufficient cognitive awareness to comply with examination procedures
- Bilateral implantation of one of the following IOL models
- Alcon PanOptix (TFNT00)
- PhysIOL FineVision (POD F)
- PhysIOL FineVision (POD F GF)
- Uneventful cataract surgery with first clinical outcomes in the expected range
- Patient included in Premium IOL study protocol by signed informed consent
Exclusion Criteria
- Age of patient <45 years
- Irregular astigmatism
- Postoperative manifested astigmatism of >1.0 D
- Difficulty for cooperation (distance from their home, general health condition)
- Clinically significant glaucoma
- Clinically significant macular degeneration, clinically significant macular edema or proliferative diabetic retinopathy
- Patients with keratoconus or keratectasia
- Any ocular comorbidity having a significant effect on the postoperative clinical outcomes
- History of ocular trauma or prior ocular surgery including refractive procedures
- Capsule or zonular abnormalities that may affect postoperative centration or tilt of the lens (e.g. pseudoexfoliation syndrome, chronic Uveitis, Marfan's syndrome)
- Pupil abnormalitis (non-reactive, tonic pupils, abnormally shaped pupils or pupils that do not dilate under mesopic/scotopic conditions)
- AMD
- Intraoperative complications like capsular rupture etc.
- Patients who do not give informed consent